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doi:10.1Objective: The use of paracorporeal ventricular assist devices has become a well-established procedure for pa-
tients with cardiogenic shock. However, implantation of ventricular assist devices is often associated with severe
complications, such as thrombosis inside the ventricular assist device and subsequent embolic events. It was the
purpose of this study to use flow-sensitive 4-dimensional magnetic resonance imaging for a detailed analysis of
the 3-dimensional (3D) flow dynamics inside a clinical routine ventricular assist device and to study the effect of
different system adjustments and a new valve design on flow patterns.
Methods: A routinely used clinical paracorporeal ventricular assist device was integrated into a magnetic
resonance-compatible mock loop. Flow-sensitive 3D magnetic resonance imaging was performed to measure
time-resolved 3-directional flow velocities (spatial resolution  1.2 mm, temporal resolution ¼ 42.4 ms) in the
entire device under ideal conditions (full fill, full empty, ejection fraction ¼ 88%), insufficient filling (ejection
fraction ¼ 81%), and insufficient emptying (ejection fraction ¼ 67%) of the pump chamber. In addition,
a new valve design was evaluated. Flexible control and monitoring of pressures at inlet and outlet were used to
generate realistic boundary conditions.
Results: Flow pattern changes for different operating conditions were clearly identified and included reduced
velocities during systolic outflow for impaired filling (78% reduction in pump flow compared with optimal
operating conditions) and impaired clearing of the pump chamber for insufficient emptying (52% reduction).
For all operating conditions, 3D visualization revealed vortex flow inside the ventricular assist device at typical
locations of thrombus formation near the valve systems. Most noticeably, the new valve design provided similar
global ventricular assist device function (pump flow 3.6 L/min), but vortex formation was eliminated.
Conclusions: The results of this study provide insight into the mechanisms underlying possible thrombus for-
mation inside a ventricular assist device and the effect of different system adjustments. The presented methods
may permit the optimization of future ventricular assist device systems with respect to optimal flow conditions.
(J Thorac Cardiovasc Surg 2011;142:1019-26)Video clip is available online.
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The Journal of Thoracic and Carthe failing heart. In recent years, a number of different sys-
tems have been introduced and have substantially improved
the outcome and survival in patients with heart failure.1-3 In
addition to devices that are fully implanted into the chest,
paracorporeal ventricular assist devices (PVADs) are also
an established treatment option for uni- or biventricular
support in acute heart failure, especially in children.4,5
PVAD implantation is often performed on a temporary
basis to serve as a bridge to transplantation or bridge to
recovery.6-11
The role of the VAD in the management of heart failure is
expanding, but there is still a high risk for complications. The
most common described complications are bleeding, infec-
tion, pericardial tamponade, respiratory events, technical
problems, and neurologic events.2,3 Thrombosis in the valve
region of a pulsatile VAD may cause embolic neurologic
events with a high rate of morbidity and mortality. Most
often, fibrin or thrombus formation in the VAD is generated
near the inflow or outflow valve or in the pump chamber as
the result of insufficient anticoagulation or a poorly adjusted
system.12,13 In addition, particular flow characteristics insidediovascular Surgery c Volume 142, Number 5 1019
FIGURE 1. Schematic representation of measurement setup for in vitro
3D flow analysis via MRI in the VAD. The VAD control unit and pressure
monitoring were placed outside the MR scanner room and connected to the
VAD flow circuit inside the scanner by long (8-m) tubing. The mock loop
used for the adjustment of pre- and afterload conditions was placed on the
patient table next to the VAD. MR, Magnetic resonance; VAD, ventricular
assist device.
Abbreviations and Acronyms
EF ¼ ejection fraction
MR ¼ magnetic resonance
MRI ¼ magnetic resonance imaging
PIV ¼ particle imaging velocimetry
PVAD ¼ paracorporeal ventricular assist device
3D ¼ 3-dimensional
4D ¼ 4-dimensional
VAD ¼ ventricular assist device
Acquired Cardiovascular Disease Benk et alA
C
Dthe VAD, such as vortex formation, flow reversal, and thus
increased residence times, may explain the high rate of
thromboembolic events after VAD implantation and the
described changes in von Willebrand factor.13
A number of studies based on different imagingmodalities
(ultrasound, particle imaging velocimetry [PIV]) or numeric
simulations (computational fluid dynamics) have investi-
gated flow patterns inside assist devices.14,15 Recently, the
application of flow-sensitive 4-dimensional (4D) magnetic
resonance imaging (MRI)16 was used for the ex vivo assess-
ment of pulsatile 3-dimensional (3D) flow characteristics in
a routine VAD implantation.17
However, to date no systematic evaluation of differentVAD
designs (eg, valve systems at inlet and outlet) on flow charac-
teristics, and thus VAD performance, has been reported. In
addition, the effect of different operating conditions, often
observed in the clinical routine (optimal vs suboptimal driving
of the device), on regional flow characteristics, and thus
risk for thrombus formation, is poorly understood.12,13,18
The purpose of this study was to use flow-sensitive 4D
MRI for a detailed analysis of 3D flow dynamics and func-
tion of the inlet and outlet valve systems in a clinical routine
VAD for different system adjustments representing optimal
and impaired operating conditions. In a second set of exper-
iments, the effect of different valve designs on regional flow
patterns and valve dynamics were directly compared. Com-
pared with previous studies, an improved magnetic reso-
nance (MR)–compatible flow circuit was developed,
including blood mimicking fluid and flexible pressure con-
trol and monitoring to provide physiologic pre- and after-
load conditions.MATERIALS AND METHODS
Magnetic Resonance-Compatible Ventricular Assist
Device Flow Circuit
The experimental setup is schematically illustrated in Figure 1. A clin-
ically used VAD (MEDOS VAD-Pump-Chamber, MEDOS Medizintech-
nik AG, Stolberg, Germany; chamber size ¼ 60 mL)4,5,19,20 was
integrated into an MR-compatible flow circuit that could be placed directly
inside a routine 3 Tesla MR system (TRIO, Siemens, Germany). Pulsatile
VAD flow was generated using pulsatile pneumatic pressure created by
a routine VAD control unit (MEDOS VAD-Driving Unit, MEDOS Medi-1020 The Journal of Thoracic and Cardiovascular Surzintechnik AG).17 As an improvement to our previous setup, a mock
loop was integrated to permit flexible pressure control via adjustment of
different water levels at inlet and outlet in combination with an adjustable
valve to simulate nearly physiologic pre- and afterload conditions similar
to strategies reported by Timms and colleagues.21 A patient monitor (Sir-
ecust, Siemens, Erlangen, Germany) was used to observe the pressure con-
ditions at the inlet and outlet of the VAD. Blood mimicking fluid was used
as blood substitute, a mixture of 60% distilled water and 40% glycerol
closely reproducing the kinematic viscosity of blood (n ¼ 0.003 m2/s).22
Magnetic Resonance 4D Flow Measurements
Time-resolved 3D phase contrast MRI with 3-directional velocity
encoding (flow-sensitive 4D MRI) was used to measure the temporal
evolution of complex 3-directional flow in a 3D volume.16,23 The fully
non-magnetic and non-metallic model systems and synchronization of
the MR data acquisition with the cyclic device function were used for
the systematic investigation of fluid dynamics inside a VAD as described
previously.17
All MR experiments were performed using a 3TMRI system (Trio, Sie-
mens). Flow-sensitive 4D data were acquired in a coronal 3D volume en-
compassing the entire VAD (field of view ¼ 154 3 280 mm, slab
thickness ¼ 62.4 mm) with a spatial resolution of 1.1 3 1.2 3 1.3 mm3
and temporal resolution of 42.4 ms.16,17,24 Further imaging parameters
were as follows: echo time ¼ 2.7 ms, repetition time ¼ 5.4 ms, velocity
sensitivity ¼ 200 cm/s, flip angle ¼ 15 degrees, and total scan time ¼ 28
minutes, 6 seconds.
Operating Conditions
To investigate the effect of different operating conditions, flow-sensitive
4D MRI was performed under ideal conditions (complete filling and
emptying), insufficient filling (expansion), and insufficient emptying (con-
traction) of the pump chamber. The different VAD operating conditions
were achieved by adjusting the systolic (PressureSystole) and diastolic
(PressureDiastole) pressure settings and the duration of the VAD systole
(TimeSystole) at the VAD control while visually inspecting the performance
of the VAD pump chamber for optimal and impaired VAD pump function.
The corresponding pump unit settings and achieved preload and afterload
pressures for all conducted flow experiments are summarized in Table 1.
The ejection fraction (EF) for all operation conditions was calculated as
EF ¼ (ADiastole- ASystole)/ADiastole by segmenting the VAD chamber areagery c November 2011
TABLE 1. Settings of the ventricular assist device control unit for the different operating conditions, including the preload and afterload conditions
for the different ventricular assist device flow experiments
VAD settings Optimal conditions Insufficient filling Insufficient emptying
Optimal conditions
and new valve design
PressureSystole 230 mm Hg 230 mm Hg 190 mm Hg 230 mm Hg
PressureDiastole 40 mm Hg 10 mm Hg 40 mm Hg 40 mm Hg
TimeSystole 35% 50% 26% 35%
Frequency 60 60 60 60
Pump flow 3.6 L/min <3.0 L/min 3.0 L/min 3.6 L/min
Preload 3–6 mm Hg 3–5 mm Hg 5–6 mm Hg 1–5 mm Hg
Afterload (systolic pressure,
diastolic pressure, MAP)
135,4, 42 mm Hg 140 ,4, 43 mm Hg 135,3, 43 mm Hg 137,7, 41 mm Hg
VAD, Ventricular assist device; MAP, mean arterial pressure.
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shown in Figure 2.
For all VAD settings, additional measurements with the pump turned off
(flow-off data), but otherwise identical data acquisition parameters, were
performed.
Ventricular Assist Device Valve Designs
The standard VAD valve design consisted of 3 bulbs at the inlet and out-
let side that were modeled according to the normal aortic root geometry,
including a model of the sinuses of Valsalva. The 3 cusps were made of
polyurethane. The inserted 3-leaflet valves were designed and adjusted in
construction and function according to the natural aortic valve. In addition,
a VAD with a new valve design was evaluated under ideal conditions, that
is, complete filling and emptying. The new valve design also consisted of 3
valve cusps, which, however, were embedded in a differently shaped geom-FIGURE 2. VAD geometry and pump chamber volume during maximum filling
gray shaded surface represents the 3D VAD geometry. For the analysis of pump
ecting the VAD chamber in horizontal (A) and vertical (B) orientation were used
were quantified and used to calculate the VAD EF.
The Journal of Thoracic and Caretry with a symmetric cylindrical shape at inlet and outlet. The VAD pump
chambers were identical for both designs. The 3 sinuses of Valsalva, used in
the standard valve design, were therefore omitted in the new valve.
Data Analysis
Flow-off data were subtracted from the velocity images to remove un-
wanted background offsets. Correction for velocity aliasing and noise
masking was performed as described previously.25
Three-dimensional visualization software (EnSight, Computational En-
gineering International, Inc, Apex, NC)was used to display 3DVADgeom-
etry using iso-surface rendering of the magnitude data (Figure 2). The
measured 3D flow characteristics inside the VAD were visualized using
3D particle traces resembling traces of massless virtual particles that
were released and path integrated in the measured time-resolved velocity
vector field. A simultaneous visualization of spatial and dynamic changes(diastole) and contraction (systole) for different operating conditions. The
chamber volume for different operating conditions, analysis planes trans-
. The maximal diastolic and minimal systolic VAD pump chamber volumes
diovascular Surgery c Volume 142, Number 5 1021
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particle traces and 3D iso-surface (Figures 3 and 4).15,16
To further evaluate the effect of operation conditions and valve design,
the velocity profiles of flow through the valves were analyzed as color-
coded velocity maps (Figure 5). In addition, flow quantification was
performed in 2-dimensional analysis planes that were manually positioned
distal to the inlet and outlet valves of the VAD.RESULTS
Three-dimensional VAD geometry and flow characteris-
tics were successfully measured in all experiments. On the
basis of the combination of themock loop and real-time pres-
sure monitoring, consistent pressure conditions (systolic
afterload¼ 135–140 mmHg, 1–6 mmHg preload) at the in-
let and outlet could be achieved as summarized in Table 1.Ventricular Assist Device Geometry
Figure 2 illustrates the 3D VAD geometry during maxi-
mum contraction (systole) and expansion (diastole) of theFIGURE 3. Three-dimensional flow visualization using time-resolved 3D part
represent the development of flow patterns during 1 VAD cycle for the VADwith
the VAD cycle is indicated by the numbers in the top left corner of each image,
successive images) of 42.4 ms. The gray shaded iso-surface rendering represents
outlet. Color coding ¼ local absolute flow velocities.
1022 The Journal of Thoracic and Cardiovascular Surpump chamber for all evaluated operating conditions. Sys-
tolic and diastolic chamber shapes are shown in 2 orthogonal
planes transecting the VAD in vertical (Figure 2, B) and hor-
izontal orientation (Figure 2, A). For insufficient filling, dia-
stolic chamber expansion was clearly reduced (Figure 2,
middle row, solid white arrows, EF ¼ 81%) compared
with optimal operating conditions (Figure 2, top row,
EF ¼ 88%). For impaired emptying, an asymmetric and in-
complete contraction of the chamber volume during systole
is clearly evident (Figure 2, lower row, open white arrows,
EF ¼ 67%).Ventricular Assist Device Flow Characteristics
Three-dimensional flow visualization was successfully
performed for all VAD measurements as illustrated in
Figure 3, which depicts VAD flow characteristics during
a complete pump cycle for the new valve design under op-
timal operating conditions. Characteristic flow patterns andicle traces in the VAD during a complete pump cycle. The series of images
the new valve design under optimal operating conditions. The time frame in
and flow dynamics are depicted with a temporal resolution (time between 2
the VAD geometry including pump chamber and valve systems at inlet and
gery c November 2011
FIGURE 4. Three-dimensional flow characteristics inside the VAD during maximum chamber expansion (end diastole) and peak outflow phase (end sys-
tole). The gray shaded area represents an iso-surface rendering of the magnitude data and shows the VAD geometry including pump chamber and valve
systems at inlet and outlet. The effect of different operating conditions in the same VAD clearly resulted in considerable differences in VAD function
(A-C). Vortex formation proximal to the inlet valve was clearly visible for all operating conditions but absent for the new valve design (D, gray arrows).
The comprehensive flow dynamics during the entire VAD cycle are clearly shown in Video 1. Color coding ¼ local absolute flow velocities.
FIGURE 5. A, Fluid velocity distribution in analysis planes at the level of the VAD inflow and outflow valves. The individual images show the velocity
profiles during peak inflow (diastole) and outflow (systole). B, Quantified time-resolved flow during 1 VAD pump cycle distal to the valve at the inlet (left)
and outlet (right). Color coding ¼ local absolute flow velocities. VAD, Ventricular assist device.
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Dthe temporal evolution of flow are depicted by 3D particle
traces and illustrate diastolic inflow (Figure 3, top row),
complex swirling and circular flow patterns during pump
chamber filling (Figure 3, second row), chamber emptying
during systole (Figure 3, third row), and outflow with
high velocities during late systole (Figure 3, lower row).
Visualization quality was similar for all other investigated
operation conditions and VADs.
Operating Conditions and Effect of Valve Design
As summarized in Figure 4, flow pattern changes for dif-
ferent operating conditions were clearly evident. Note the
different geometries of the standard valve housing (aortic
root shape) and the new design (cylindrical shape). Com-
pared with normal operating conditions, insufficient VAD
filling resulted in reduced velocities during systolic outflow.
The low numbers of end-diastolic particle traces inside the
pump chamber (Figure 4, white arrows) indicate reduced in-
flow compared with optimal conditions.
Insufficient emptying led to impaired clearing of the
pump chamber (Figure 4, yellow arrows) while maintaining
high systolic outflow velocities. Potentially thrombogenic
vortex formation proximal to the inlet valve was clearly vis-
ible for all operating conditions (Figure 4, gray arrows).
A novel valve design using a differently shaped valve
support region resulted in improved VAD performance. In
addition to improved filling of the outflow cannula, vortex
formation proximal to the inflow valve was virtually elimi-
nated.
Valve Flow Profiles and Quantification
The results of the flow profile analysis and quantification
at the level of the inlet and outlet valves are summarized in
Figure 5.
The standard VAD valves open in a star-shape at both in-
let and outlet as determined by the valve geometry. Despite
normal operating conditions (Figure 5,A, top row), the valve
opening area and velocity distribution appeared asymmet-
ric, and only 1 of the valvular cusps was fully opened at
the outflow valve (Figure 5, white arrows). Impaired operat-
ing conditions (Figure 5, A, rows 2 and 3) clearly altered the
shape and size of the valve opening area at inlet and outlet.
The worst performance was observed for insufficient filling
demonstrating reduced flow velocities during the entire
pump cycle and altered valve dynamics, including opened
inlet valves during systole (Figure 5, black arrows). The
new valve design (Figure 5, A, row 4) resulted in a more
symmetric valve opening area and homogenous velocity
distributions at inlet and outlet.
As expected, flow quantification revealed impaired per-
formance for insufficient emptying (Figure 5, B, diamonds)
and particularly insufficient filling (Figure 5, circles). Nor-
mal operating conditions for the standard VAD resulted in
a total VAD outflow of 3.7 L/min. Insufficient filling and1024 The Journal of Thoracic and Cardiovascular Suremptying clearly reduced VAD function by 78% and
52% to 1.9 L/min and 2.8 L/min, respectively. The VADs
with standard (squares) and novel (open triangles) valve de-
sign demonstrated almost identical flow behavior (total
flow ¼ 3.6 L/min).
DISCUSSION
Flow-sensitive MRI and advanced 3D flow visualization
methods were used to derive a comprehensive picture of
flow dynamics within the VAD system for different operat-
ing conditions and valve designs. The data could success-
fully be used to evaluate the dynamics of pump chamber
volume and valve function at inlet and outlet. The identifi-
cation of complex flow patterns, such as vortex formation,
and the observed differences in valve opening and closing
dynamics point toward the potential of the presented
methodology to further deepen the understanding of VAD
function.
As expected, different operating conditions for the same
VAD resulted in considerable altered VAD function. The re-
sults clearly showed the importance of an optimally ad-
justed system to avoid filling and emptying problems of
the artificial ventricle that prevent achieving a perfect wash-
out of the system. In addition to the expected reduction of
total VAD pump performance for insufficient filling or emp-
tying, that is, poor washout of the ventricle, marked alter-
ations in valve function (Figure 5, A), and pulsatile flow
dynamics (Figure 5, B) were observed.
The highest incidence of inadequate system performance
in clinical routine results from insufficient filling of the ar-
tificial ventricle. These findings therefore indicate that such
operating conditions not only result in an inadequate sup-
port of the patient but also affect valve function and regional
flow patterns. We hypothesize that the observed low veloc-
ities near the valve systems and prolonged valve opening
duration may result in increased risk of fibrin and thrombus
accumulation.
For the standard VAD, complex flow and particularly
pronounced end-systolic vortex formation were seen inde-
pendently of system adjustments. These findings provide
practical insight regarding a potential mechanism for
thrombus formation inside a VAD. Vortex flow can result
in altered blood shear rates and increased residence times,
which are known to promote the development of thrombi.
Although no direct link between the flow patterns and the
existence of thrombi was demonstrated, the location of
the flow vortex near the inlet valve systems corresponds
well with the region of frequent thrombus occurrence
observed in clinical routine.
Initial results from flow pattern analysis in a VADwith an
alternative valve design indicated an improved washout and,
most noticeably, the complete absence of vortex flow near
the valve systems. In addition, the altered valve geometry re-
sulted in a more symmetric circular valve opening area. Wegery c November 2011
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more homogenous velocity distribution inside the valve
and consequently less flow disturbance and reduced risk
for vortex formation. These preliminary findings indicate
the potential of in vitro experiments to optimizeVADdesign.
It should be noted that the new valves are still an exper-
imental design and have not yet been used clinically. How-
ever, our results show improved flow characteristics for this
new type of valve. The major limitation of the standard
valve design has been thrombus formation.26 In our own
clinical experience, thrombi were especially found in the si-
nuses of Valsalva. This thrombin generation was the main
reason for pump exchange in up to 50% of patients. How-
ever, thrombus formation is also a major complication in
other paracorporeal pulsatile VADs.27
These findings regarding regional flow alterations should
be interpreted with care. Areas of turbulence or complex
flow as seen near the VAD valves may lead to pockets of sta-
sis and increased thrombogenicity. However, areas of com-
plex flow and thus potentially increased shear stress may
also lead to an acquired factor VIII deficiency and therefore
less thrombogenicity and increased bleeding tendency. Ele-
vated shear stress may also result in increased hemolysis
without increased thrombogenicity. Moreover, Virchow’s
triad of thrombus formation involves an injury to the vessel,
a change in the blood’s innate thrombogenicity, and an al-
teration in the flow pattern. It is important to note that the
presented model only addresses 1 of these 3 components
and therefore has limited ability to predict the actual clinical
outcome. Animal studies or experiments with real blood are
therefore needed to evaluate the true impact of the observed
flow alterations.
The presented technique implies a number of limitations.
All measurements were performed using an in vitro mock
loop model, filled with a fluid similar to blood, with flexibly
adjustable pressure conditions. Although care was taken to
simulate in vivo conditions as closely as possible, the pres-
sure conditions at inlet and outlet and the total pump flow
were somewhat suboptimal. Therefore, the interpretation
of the results with respect to the situation in the clinical
routine must be considered carefully. The in vitro model
allowed a maximum pump frequency of 60/min (3.6
L/min) because of the capacitance of the long pneumatic
tubings that were necessary to connect the VAD to the
pump unit outside the scanner room. The range of possible
heart rates and pressure conditions was thus limited. More-
over, the use of real blood instead of blood mimicking fluid
may alter the observed flow patterns in the VAD. Future
studies are therefore needed with an improved model sys-
tem that permits higher VAD output and frequencies to sys-
tematically evaluate the influence of these parameters on
VAD function. In addition, the model could be refined to
permit evaluation of the influence of individual VAD can-
nula positions relative to the heart.The Journal of Thoracic and CarA further limitation of the presented in vitro setup is re-
lated to the isolated evaluation of the VAD under different
operating conditions or with a novel valve design. In inves-
tigations of optimal pumping specifications, the influence of
left ventricular ejection on filling and washing of the pump
has been ignored. Future experiments should include ani-
mal studies that could provide an ideal setting to model
the complete system (left ventricle plus VAD) and its reac-
tion to different operating conditions and VAD designs.28
The in vitro experiments presented in this study were
based on a pulsatile VAD that was introduced several years
ago. Given the rapid advancements in VAD technology, spe-
cifically the current transition from pulsatile to continuous
flow systems, future studies should include different and
continuous-flow devices.29,30 A drawback of the MR-
based device characterization is related to the need for
non-magnetic and largely non-metallic assist devices. The
presence of magnetic or metallic materials could make
the measurements impossible or result in substantial imag-
ing artifacts. As a remedy, existing devices might be repli-
cated using MR-compatible materials and then used for in
vitro flow assessment.
Because no imaging technology exists to measure 3D
flow inside a clinical VAD implanted in a patient, the in vitro
setup may provided a useful model system using real VAD
equipment and near physiologic conditions. Alternatively,
numeric simulations using computational fluid dynamics
have been applied in a number of studies.14,15 However,
boundary conditions are often simplified, and it is difficult
to accurately model the clinical equipment. The advantage
of the presented approach is related to the use of
a standard clinical VAD and pump units and real
measurement of time-resolved 3-directional fluid velocities.
It should be noted that the method used for 3D visualiza-
tion of fluid flow (time-resolved particle traces) did not in-
volve true physical particles that were present in the fluid in
the VAD. Instead, a computer algorithm was used that
traced the temporal behavior of virtual massless particles
that were released inside the VAD. By repeated virtual par-
ticle emission over time, the calculated traces represent
a collection of continuously propagating streaks that travel
through the flow field according to the measured speeds and
directions of flow. The animation of these traces (Video E1)
provides a visual impression of time-resolved fluid flow.26
An alternative modality to investigate 3D fluid dynamics
in model systems is provided by optical imaging tech-
niques, such as PIV.15 A number of studies have shown
that PIV can provide highly accurate depiction of fluid dy-
namics by tracing the evolution of suspended particles in
a dynamically changing fluid. However, disadvantages of
PIV include the need for matching the refraction index of
the model systems and the fluid under investigation. These
limitations do not apply to flow-sensitive MRI, which can
be used to measure flow velocities in nontransparent modelsdiovascular Surgery c Volume 142, Number 5 1025
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consuming (several hours of scan time) and requires
extensive postprocessing to derive particle traces. MRI
measurements of the pulsatile 3D flow field, on the other
hand, can be performed on the order of 30 minutes and
are thus advantageous if different operating conditions are
successively evaluated in 1 imaging session. Disadvantages
of MRI compared with PIV include the requirement of fully
non-magnetic and non-metallic model systems and the high
cost of operating an MR system.CONCLUSIONS
We presented the first evaluation of flow dynamics of
a VAD connected to a mock loop under different operating
conditions. Our findings indicate the feasibility of in vitro
VAD analysis to improve the understanding of flow charac-
teristics, pump chamber geometry, and valve dynamics un-
der different system adjustments. Direct comparison with
a new valve design showed the potential of this technique
to improve the VAD designs under in vitro conditions with-
out the need for complex computer simulations or animal
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